Removal efficiencies of organic micropollutants in wastewater-based reclaimed water by two different treatment processes

Zhongguo Huanjing Kexue/China Environmental Science

Volumn 29, Issue 8, 2009, Pages 816-821

  Zhou, Hai Dong ^a   Huang, Xia ^a   Wang, Xiao Lin ^b   Gao, Mi Jun ^b   Wen, Xiang Hua ^a  

^a TSINGHUA UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY BEIJING   (China)

Author keywords

Environmental risk; Organic micropollutant; Reclaimed water

Indexed keywords

EID: 70249101781     PISSN: 10006923     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Carballa M, Omil F, Lema J M, et al. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant[J]. Water Research, 2004, 38(12): 2918-2926.
2. Zhou H, Huang X, Wang X, et al. Behaviour of selected endocrine disrupting chemicals in three sewage treatment plants of Beijing, China[J]. Environmental Monitoring and Assessment, 2009. doi: 10.1007/s10661-008-0731-6.
3. 2004, 25(1): 114-116.
4. 2005, 21(12): 94-97.
5. Zhou H, Huang X, Gao M, et al. Distribution and elimination of polycyclic musks in three sewage treatment plants of Beijing, China[J]. Journal of Environmental Sciences, 2009, 21(5): 561-567.
6. 2008.
7. Ternes T A, Stuber J, Herrmann N, et al. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?[J]. Water Research, 2003, 37(8): 1976-1982.
8. Gomez M, Garralon G, Plaza F, et al. Rejection of endocrine disrupting compounds (bisphenol A, bisphenol F and triethyleneglycol dimethacrylate) by membrane technologies[J]. Desalination, 2007, 212(1-3): 79-91.
9. Comerton A M, Andrews R C, Bagley D M, et al. Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds[J]. Journal of Membrane Science, 2007, 303(1/2): 267-277.
10. Clara M, Strenn B, Gans O, et al. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants[J]. Water Research, 2005, 39(19): 4797-4807.
11. Yoon Y, Westerhoff P, Snyder S A, et al. Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes[J]. Desalination, 2007, 202(1-3): 16-23.
12. Ternes T A, Meisenheimer M, McDowell D, et al. Removal of pharmaceuticals during drinking water treatment[J]. Environmental Science and Technology, 2002, 36(17): 3855-3863.
13. Huber M M, Canonica S, Park G Y, et al. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes[J]. Environmental Science and Technology, 2003, 37(5): 1016-1024.
14. Zwiener C, Frimmel F H. Oxidative treatment of pharmaceuticals in water[J]. Water Research, 2000, 34(6): 1881-1885.
15. Nakada N, Yasojima M, Okayasu Y, et al. Fate of oestrogenic compounds and identification of oestrogenicity in a wastewater treatment process[J]. Water Science and Technology, 2006, 53(11): 51-63.
16. Reif R, Suárez S, Omil F, et al. Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage[J]. Desalination, 2008, 221(1-3): 511-517.
17. Agenson K O, Oh J-I, Urase T. Retention of a wide variety of organic pollutants by different nanofiltration/reverse osmosis membranes: controlling parameters of process[J]. Journal of Membrane Science, 2003, 225(1/2): 91-103.